<DOC>
	<DOCNO>NCT00233506</DOCNO>
	<brief_summary>- CpG potential stimulate immune system - study evaluate safety CpG give sub-q IV - purpose measure biological change CLL cell receive CpG</brief_summary>
	<brief_title>A Dose Finding Study CpG Patients With Chronic Lymphocytic Leukemia Who Have Been Previously Treated</brief_title>
	<detailed_description />
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<mesh_term>Leukemia , Lymphocytic , Chronic , B-Cell</mesh_term>
	<criteria>Diagnosis CLL CLL previously treat Hemoglobin &gt; /= 10 Platelets &gt; /= 50,000 Neutrophils &gt; = 1,000 patient brain mets patient autoimmune disease patient corticosteroids immunosuppressant patient uncontrolled intercurrent illness pregnant woman HIV patient receive combination antiretroviral therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>CpG 7909</keyword>
	<keyword>CLL</keyword>
</DOC>